95 related articles for article (PubMed ID: 20631625)
61. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.
Hakonarson H; Bjornsdottir US; Halapi E; Bradfield J; Zink F; Mouy M; Helgadottir H; Gudmundsdottir AS; Andrason H; Adalsteinsdottir AE; Kristjansson K; Birkisson I; Arnason T; Andresdottir M; Gislason D; Gislason T; Gulcher JR; Stefansson K
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14789-94. PubMed ID: 16203992
[TBL] [Abstract][Full Text] [Related]
62. Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).
Birerdinc A; Afendy A; Stepanova M; Younossi I; Baranova A; Younossi ZM
Brain Behav; 2012 Sep; 2(5):525-31. PubMed ID: 23139898
[TBL] [Abstract][Full Text] [Related]
63. Perihepatic lymphadenopathy and the response to therapy in chronic hepatitis C patients().
Longo S; Cotella G; Carletta F; Catacchio M; Antonaci S
J Ultrasound; 2010 Dec; 13(4):164-7. PubMed ID: 23396905
[TBL] [Abstract][Full Text] [Related]
64. Neopterin as a marker of response to antiviral therapy in hepatitis C virus patients.
Oxenkrug GF; Requintina PJ; Mikolich DL; Ruthazer R; Viveiros K; Lee H; Summergrad P
Hepat Res Treat; 2012; 2012():619609. PubMed ID: 22811898
[TBL] [Abstract][Full Text] [Related]
65. Low-dose oral interferon modulates expression of inflammatory and autoimmune genes in cattle.
Mamber SW; Lins J; Gurel V; Hutcheson DP; Pinedo P; Bechtol D; Krakowka S; Fields-Henderson R; Cummins JM
Vet Immunol Immunopathol; 2016 Apr; 172():64-71. PubMed ID: 27032505
[TBL] [Abstract][Full Text] [Related]
66. Transcriptional network predicts viral set point during acute HIV-1 infection.
Chang HH; Soderberg K; Skinner JA; Banchereau J; Chaussabel D; Haynes BF; Ramoni M; Letvin NL
J Am Med Inform Assoc; 2012; 19(6):1103-9. PubMed ID: 22700869
[TBL] [Abstract][Full Text] [Related]
67. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays.
Schlaak JF; Hilkens CM; Costa-Pereira AP; Strobl B; Aberger F; Frischauf AM; Kerr IM
J Biol Chem; 2002 Dec; 277(51):49428-37. PubMed ID: 12386168
[TBL] [Abstract][Full Text] [Related]
68. Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma.
Tomiyama Y; Yoshioka N; Yanai Y; Kawase T; Nishina S; Hara Y; Yoshida K; Korenaga K; Korenaga M; Hino K
Hepat Med; 2011; 3():45-52. PubMed ID: 24367220
[TBL] [Abstract][Full Text] [Related]
69. Pharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms.
Ke WS; Hwang Y; Lin E
Adv Appl Bioinform Chem; 2010; 3():39-44. PubMed ID: 21918625
[TBL] [Abstract][Full Text] [Related]
70. Prognosis of chronic hepatitis C patients correlates with circulating monocyte/macrophage function.
Yamashiki M; Nishimura A; Suzuki H
Clin Sci (Lond); 1997 Oct; 93(4):381. PubMed ID: 9404231
[No Abstract] [Full Text] [Related]
71. Cell subset prediction for blood genomic studies.
Bolen CR; Uduman M; Kleinstein SH
BMC Bioinformatics; 2011 Jun; 12():258. PubMed ID: 21702940
[TBL] [Abstract][Full Text] [Related]
72. Analysis of Glaucoma Associated Genes in Response to Inflammation, an Examination of a Public Data Set Derived from Peripheral Blood from Patients with Hepatitis C.
Player JK; Riordan SM; Duncan RS; Koulen P
Clin Ophthalmol; 2022; 16():2093-2103. PubMed ID: 35770250
[TBL] [Abstract][Full Text] [Related]
73. Correction to:
J Interferon Cytokine Res; 2019 May; 39(5):315. PubMed ID: 30990735
[No Abstract] [Full Text] [Related]
74. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.
Sun B; Abadjian L; Monto A; Freasier H; Pulliam L
J Infect Dis; 2020 Jul; 222(3):396-406. PubMed ID: 32157304
[TBL] [Abstract][Full Text] [Related]
75. Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent.
O'Connor KS; Parnell G; Patrick E; Ahlenstiel G; Suppiah V; van der Poorten D; Read SA; Leung R; Douglas MW; Yang JY; Stewart GJ; Liddle C; George J; Booth DR
Genes Immun; 2014 Mar; 15(2):88-94. PubMed ID: 24335707
[TBL] [Abstract][Full Text] [Related]
76. The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells.
François C; Coulouarn C; Descamps V; Castelain S; Brochot E; Baron A; Duchaussoy I; Capron D; Nguyen-Khac E; Duverlie G
Antimicrob Agents Chemother; 2012 Feb; 56(2):903-8. PubMed ID: 22123700
[TBL] [Abstract][Full Text] [Related]
77. Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h.
Devitt E; Lawless MW; Sadlier D; Browne JA; Walsh C; Crowe J
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1211-20. PubMed ID: 20631625
[TBL] [Abstract][Full Text] [Related]
78. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
[TBL] [Abstract][Full Text] [Related]
79. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy.
Taylor MW; Tsukahara T; Brodsky L; Schaley J; Sanda C; Stephens MJ; McClintick JN; Edenberg HJ; Li L; Tavis JE; Howell C; Belle SH
J Virol; 2007 Apr; 81(7):3391-401. PubMed ID: 17267482
[TBL] [Abstract][Full Text] [Related]
80. Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
Angelico M; Koehler-Horst B; Piccolo P; Angelico F; Gentile S; Francioso S; Tarquini P; Vecchia RD; Ponti L; Pilleri G; Barlattani A; Grieco A; Soccorsi F; Guarascio P; Demelia L; Sorbello O; Rossi Z; Forlini G; Zaru S; Bandiera F;
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):680-7. PubMed ID: 18679072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
